Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Open accessThe DOI matches its Crossref record; 128 of the 130 references it cites were found in a registry or an index.
Abstract
This paper discusses the current evidence from animal and human studies for a central role of inflammation in schizophrenia. In animal models, pre- or perinatal elicitation of the immune response may increase immune reactivity throughout life, and similar findings have been described in humans. Levels of pro-inflammatory markers, such as cytokines, have been found to be increased in the blood and cerebrospinal fluid of patients with schizophrenia. Numerous epidemiological and clinical studies have provided evidence that various infectious agents are risk factors for schizophrenia and other psychoses. For example, a large-scale epidemiological study performed in Denmark clearly showed that severe infections and autoimmune disorders are such risk factors. The vulnerability-stress-inflammation model may help to explain the role of inflammation in schizophrenia because stress can increase pro-inflammatory cytokines and may even contribute to a chronic pro-inflammatory state. Schizophrenia is characterized by risk genes that promote inflammation and by environmental stress factors and alterations of the immune system. Typical alterations of dopaminergic, serotonergic, noradrenergic, and glutamatergic neurotransmission described in schizophrenia have also been found in low-level neuroinflammation and consequently may be key factors in the generation of schizophrenia symptoms. Further support for the relevance of a low-level neuroinflammatory process in schizophrenia is provided by the loss of central nervous system volume and microglial activation demonstrated in neuroimaging studies. Last but not least, the benefit of anti-inflammatory medications found in some studies and the intrinsic anti-inflammatory and immunomodulatory effects of antipsychotics provide further support for the role of inflammation in this debilitating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence of altered inflammation-related markers across psychiatric conditions [6–8], along with reports of anti-inflammatory effects from psychotropic medications [9, 10] and the ameliorative impact of anti-inflammatory drugs on psychiatric symptoms [11–14], suggests a strong link between abnormal inflammatory responses and major psychiatric disorders.”
From Inflammatory ratios as predictors of length of hospitalization in psychiatric patients: A multicenter study (2025) · doi:10.1007/s00406-025-02033-9 · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A growing body of evidence suggests that immune dysfunction and inflammation have been considered to play important roles in the pathogenesis of SCZ and BD (11, 12).”
From Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Changes of some inflammation-related factors (IRFs) have been intensively studied and reviewed in relation to psychiatric disorders1–9.”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Recent evidence suggests the involvement of the immune system in several psychiatric conditions [203–205]; one of the most studied in this respect is depression [206–208].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murphy, K., & Weaver, C. (2016) · W.W. Norton eBooks · doi:10.1201/9781315533247 · Cited by 2,258
Vulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.2.103 · Cited by 1,992
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.774 · Cited by 1,053
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Cited by
Items 301–400 of 648
Casas, B. S., Arancibia‐Altamirano, D., Rosa, F. A.-L., Garrido-Jara, D., Maksaev, V., Pérez-Monje, D., & Palma, V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.946706 · Cited by 9
“There is considerable evidence showing increased levels of proinflammatory molecules in the brain, blood, and cerebrospinal fluid of SZ patients (Fillman et al., 2013; Müller, 2018).”
BackgroundSocial interaction, psychotic disorders and inflammation: A triangle of interest
Faustmann, T. J., Kamp, D., Räuber, S. J., Dukart, J., Melzer, N., & Schilbach, L. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110697 · Cited by 9
Yuhas, Y., Ashkenazi, S., Berent, E., & Weizman, A. (2022) · Brain Sciences · doi:10.3390/brainsci12121703 · Cited by 9
Dixon, T., & Cadenhead, K. S. (2023) · Trials · doi:10.1186/s13063-023-07789-w · Cited by 9
“Neurochemical changes associated with neuroinflammation have also been associated with the symptoms of schizophrenia [49].”
BackgroundMani, V., & Alshammeri, B. S. (2023) · Medicina · doi:10.3390/medicina60010046 · Cited by 9
“MyBioSources Inc. (San Diego, CA, USA).”
Neurobiochemical Disturbances in Psychosis and their Implications for Therapeutic Intervention
Panov, G., & Panova, P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266282773240116073618 · Cited by 10
Gasnier, M., Ellul, P., Plaze, M., & Abdel-Ahad, P. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.3.395 · Cited by 7
“BH4 is derived from neopterin, an enzyme activated by inflammatory cytokines [16].”
BackgroundRe-inventing the schizophrenia syndrome: The elusive “theory of everything”
Nasrallah, H. A. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.11.006 · Cited by 8
Circular RNAs in extracellular vesicles: Promising candidate biomarkers for schizophrenia
Chuang, G., Lv, H., Bai, Y., Guo, M., Li, P., Tong, S., & He, K. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.997322 · Cited by 11
“Increasing evidences suggested that inflammation contributes to occurrence and development of schizophrenia (van Beveren et al., 2014; Muller, 2018).”
BackgroundFunctional Nutrition as Integrated Intervention for In- and Outpatient with Schizophrenia
Matrisciano, F. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230322160259 · Cited by 9
“…in tryptophan metabolism and the kynurenine pathway, which is also stimulated by pro-inflammatory cytokines, and the neuroactive metabolite kynurenic acid acts, in turn, as an NMDA receptors antagonist linking the glutamate hypothesis of schizophrenia to inflammation and glia activation [41, 42].”
BackgroundDunleavy, C., Elsworthy, R. J., Wood, S. J., Allott, K., Spencer, F. S. E., Upthegrove, R., & Aldred, S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.06.017 · Cited by 11
“The ‘two-hit ’ hypothesis of SCZ suggests that genetic perturbations increase the risk of poor immune responses to stress, and repeated stress exposure functions to bring about disease pathology in early adulthood (Müller, 2018).”
BackgroundPan, B., Li, X., Weng, J., Xu, X., Yu, P., Zhao, Y., Yu, D., Zhang, X., & Tang, X. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111302 · Cited by 8
González, J. L. S., Sánchez-Gil, A., Vicente-Muñoz, E., Navarro‐López, V., Martín‐Vallejo, J., & Pérez, J. M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.04.001 · Cited by 10
The role of neuroinflammation in schizophrenia: Focus on Th17 cells functions
Melnikov, M., Lopatina, A., Sviridova, A., Chugunov, A. V., Vavilis, T., Stamatellos, V., Stamoula, Ε., & Cosentino, M. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104629 · Cited by 8
Schizophrenia Spectrum and Other Psychotic Disorders
Burns, A. V., & Marder, S. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-15401-0_15 · Cited by 9
Facal, F., Arrojo, M., Páramo, M., & Costas, J. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01786-z · Cited by 7
“Inflammation and immunity have been implicated in the etiology of schizophrenia [9].”
Gluten-Free Diet Lowers Oxidative Stress for Gluten-Sensitive Persons with Schizophrenia
Kim, E., Redwood, S., Liu, F., Roche, D. J. O., Chen, S., Bentley, W. E., Eaton, W. W., Čiháková, D., Talor, M. V., Kelly, D. L., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.05.001 · Cited by 7
Lorkiewicz, P., & Waszkiewicz, N. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1423739 · Cited by 11
“Notably, in SCZ, there is considerable discussion regarding the effects of pre-or perinatal exposure to infections or generalized in fl ammation on immune reactivity throughout life, thereby increasing the risk of developing SCZ (Brown, 2006; Brown, 2011; Müller, 2018).”
BackgroundThe Effects of Ibuprofen Consumption on the Incidence of Postpartum Depression
Kapulsky, L., Christos, P. J., Ilagan, J., & Kocsis, J. H. (2021) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000448 · Cited by 7
Parasites, Pussycats and Psychosis: The Unknown Dangers of Human Toxoplasmosis
Torrey, E. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-86811-6 · Cited by 15
Microglial reactivity in the prefrontal cortex in different types of schizophrenia
Vikhreva, O. V., & Uranova, N. A. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112112177 · Cited by 7
Chamera, K., Curzytek, K., Kamińska, K., Trojan, E., & Basta‐Kaim, A. (2022) · Cells · doi:10.3390/cells11182788 · Cited by 9
James, L. M., Charonis, S. A., & Georgopoulos, A. P. (2023) · Neuroscience Insights · doi:10.1177/26331055231166411 · Cited by 8
Yang, C., Tian, Y., Yang, X., Liu, L., Chen, L., Xia, L., & Liu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337103 · Cited by 10
Faustmann, T. J., Corvace, F., Faustmann, P. M., & Ismail, F. S. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1522128 · Cited by 11
Aymerich, C., Pedruzo, B., de Pablo, G. S., Labad, J., McCutcheon, R. A., Pillinger, T., Torres, M. Á. G., Sánchez‐Gistau, V., Oliver, D., Alconada, D. A., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.009 · Cited by 11
“…‘vulnerability-stress-inflammation ’ model of schizophrenia development, which posits that stressor-induced pro-inflammatory situations in early life can cause chronic inflammation that perturbs neurotransmitter systems, eventually leading to psychotic symptom presentation (Norbert Müller, 2018).”
Barone, A., Vellucci, L., Ciccarelli, M., Matrone, M., Simone, G. D., Iannotta, F., Iasevoli, F., & de Bartolomeis, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178598 · Cited by 9
“A growing body of evidence from clinical, preclinical, and postmortem studies supports the hypothesis that immune activation contributes to the pathophysiology of resistance to antipsychotics [183–187].”
Peng, S., Geng, X., Huen, W. W. K., Fang, C. Z., Chan, J. K. N., Chu, R. S. T., Chen, E. Y. H., Chan, S. K. W., Lee, E. H. M., Hui, C. L. M., et al. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.12.014 · Cited by 6
A Sex-Dependent Association Between Doxycycline Use and Development of Schizophrenia
de Witte, L. D., Laursen, T. M., Corcoran, C. M., Kahn, R. S., Birnbaum, R., Munk‐Olsen, T., & Bergink, V. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad008 · Cited by 6
Guan, X., Leng, W., Hu, Q., Xiu, M., & Zhang, X. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106386 · Cited by 7
Guo, P., Meng, C., Zhang, S., Cai, Y., Huang, J., Shu, J., Wang, J., & Cai, C. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109802 · Cited by 7
Голимбет, В. Е., & Klyushnik, T. P. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212210166 · Cited by 7
Serum Growth Factors in Schizophrenia Patients
Boiko, A. S., Mednova, I. A., Kornetova, E. G., Bokhan, N. A., & Ivanova, S. А. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040215 · Cited by 7
Shangguan, F., Chen, Z., Lv, Y., & Zhang, X. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.07.039 · Cited by 7
Gibbs, A., Maripuu, M., Öhlund, L., Widerström, M., Nilsson, N., & Werneke, U. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05629-y · Cited by 8
“Differences in immunological profile [51], barriers to somatic care [52], socioeconomic [53], social and environmental factors may all play a role.”
BackgroundCompensatory thickening of cortical thickness in early stage of schizophrenia
Wang, Y., Fan, L., He, Y., Yuan, L., Li, Z., Zheng, W., Tang, J., Li, C., Jin, K., Liu, W., et al. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae255 · Cited by 8
Koçak, M. B., Atkaya, N. Ö., & Oruç, M. A. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2378180 · Cited by 9
Özsoy, F., Demir, F. Ü., & Taşçı, G. (2021) · Journal of Forensic Psychiatry and Psychology · doi:10.1080/14789949.2020.1870708 · Cited by 7
“chronic inflammation plays a role in chronic psychiatric diseases such as schizophrenia and BAD (Müller, 2018; Muneer, 2016).”
BackgroundInfluentialUsing protein turnover to expand the applications of transcriptomics
Smail, M. A., Reigle, J. K., & McCullumsmith, R. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-83886-7 · Cited by 9
Siwik, D., Gajewska, M., Karoń, K., Pluta, K., Wondołkowski, M., Wilimski, R., Szarpak, Ł., Filipiak, K. J., & Gąsecka, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112317 · Cited by 8
“As schizophrenia has an inflammatory background, ASA is recommended also in the treatment of the first episode of schizophrenia [80].”
BackgroundNeuroinflammation in Schizophrenia
Mawey, F. M., Karimah, A., Limoa, E., & Nazmuddin, M. (2021) · Jurnal Psikiatri Surabaya · doi:10.20473/jps.v10i1.20871 · Cited by 8
“chronic episodes), drugs, and other interfering factors may all play a role in the contradictory results [7], [10], [11]”
BackgroundResultConsidering alternatives to the schizophrenia construct
Gur, R. E. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2021.12.027 · Cited by 6
Rittmannsberger, H., Barth, M., Malík, P., Malsiner‐Walli, G., & Yazdi, K. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.11 · Cited by 6
“In a substantial proportion of schizophrenic patients, elevated markers of inflammation have been found, and the ‘ vulnerability-stress-inflammation ’ model of schizophrenia was proposed (Müller et al ., 2015; Müller, 2018).”
BackgroundMatrisciano, F. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173589 · Cited by 6
Keřková, B., Knížková, K., Večeřová, M., Šustová, P., Fürstová, P., Hrubý, A., Španiel, F., & Rodríguez, M. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.09.034 · Cited by 7
Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice
Schoonover, K. E., McMeekin, L. J., Farmer, C. B., Varghese, N. E., Queern, S. L., Lapi, S. E., Cowell, R. M., & Roberts, R. C. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.024 · Cited by 5
“It has been repeatedly suggested that SZ is a disease of inflammation (Muller, 2018), which is consistent with the serum and cerebrospinal fluid Schoonover et al.”
ResultKonen, F. F., Gehring, P. S., Maier, H. B., Schröder, S., Türker, S. N., Frieling, H., Bleich, S., Huss, A. M., Tumani, H., Lüdecke, D., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-13367-8 · Cited by 6
“…of patients with paranoid schizophrenia characterized by inflammation-related neuro-axonal damage (NFL), it raises questions about the potential benefit of immunomodulatory treatment for these individuals and of the implementation of neuroimaging controls and repeated CSF analyses 11,12,25,29 .”
Wu, Y., Su, B., Zhao, Y., Chen, C., Tian, Y., & Zheng, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120025 · Cited by 6
Ashique, S., Paul, D., Debnath, B., Chellappan, D. K., Das, J., Bhui, U., Ramzan, M., Sharma, N., Kumar, B., Sridhar, S. B., et al. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2560658 · Cited by 8
“At the same time, oxidative stress, the condition of imbalance between the reactive oxygen species (ROS) and antioxidant defenses, has been related to neurodegeneration and synaptic dysfunction in schizophrenia [104].”
The Role of Fatty Acid Binding Proteins in Neuropsychiatric Diseases: A Narrative Review
Powell, A., Yamaguchi, N., Lu, H., Pareek, O., Elman, I., Gold, M. S., Pinhasov, A., Blum, K., & Thanos, P. K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26812 · Cited by 5
Mekori‐Domachevsky, E., Taler, M., Weinberger, R., Guri, Y., Dar, S., Shani, S., Dekel, I., Weizman, A., & Gothelf, D. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.03.023 · Cited by 6
Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options
Khan, M. M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104919 · Cited by 5
Hair zinc levels and psychosis risk among adolescents
Tabata, K., Miyashita, M., Yamasaki, S., Toriumi, K., Ando, S., Suzuki, K., Endo, K., Morimoto, Y., Tomita, Y., Yamaguchi, S., et al. (2022) · Schizophrenia · doi:10.1038/s41537-022-00307-y · Cited by 6
Pain Management - From Acute to Chronic and Beyond
Aslanidis, T., & Nouris, C. (2023) · Pharmaceutical science. · doi:10.5772/intechopen.107760 · Cited by 6
Anti-SFT2D2 autoantibodies alter dendrite spine and cause psychotic behavior in mice
Liu, D., Jin, Z., Wei, H., Zhu, C., Liu, K., You, P., Ju, J., Xu, J., Zhu, W., & Xu, Q. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.01.015 · Cited by 5
Chen, Z., Li, Y., Gao, Y., Fan, X., Du, X., Li, X., Liu, Z., Liu, S., & Cao, X. (2024) · BMC Immunology · doi:10.1186/s12865-024-00618-y · Cited by 6
“However, some studies have suggested that dysregulation of the central nervous system’s (CNS) immune processes may be a pathogenesis of SCZ [4, 5].”
BackgroundBridging cholinergic signalling and inflammation in schizophrenia
Metz, C. N., Brines, M. L., & Pavlov, V. A. (2024) · Schizophrenia · doi:10.1038/s41537-024-00472-2 · Cited by 7
Inflammatory Hematological Ratios in Adolescents with Mental Disorders: A Scoping Review
Popov, M. Y., Popov, Y. V., Kosterin, D. N., & Lepik, O. V. (2024) · Consortium Psychiatricum · doi:10.17816/cp15514 · Cited by 12
“There is also evidence of activation of immune and inflammatory mechanisms in mental disorders such as depression [8–10], schizophrenia [8, 11, 12], and anxiety disorders [13].”
BackgroundBridging the gap: Prenatal nutrition, myelination, and schizophrenia etiopathogenesis
Ortiz‐Valladares, M., González-Pérez, Ó., & Pedraza‐Medina, R. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.08.019 · Cited by 8
Glinert, A., Zlidennyy, V., Turjeman, S., Sharon, E., Schweitzer, R., Khatib, S., Izakson, L., & Koren, O. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116196 · Cited by 5
Alkol ve madde kullanım bozukluğu tanılı hastalarda inflamasyon düzeyleri
Kulu, M., Özsoy, F., & Demir, B. (2021) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.975848 · Cited by 6
Изнак, Е. В., Изнак, А. Ф., Oleichik, I. V., & Zozulya, S. A. (2021) · Human Physiology · doi:10.1134/s0362119721050054 · Cited by 6
Schick, B., Barth, E., Mayer, B., Weber, C.-L., Hagemeyer, T., & Schönfeldt‐Lecuona, C. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050501 · Cited by 7
Sato, Y., KUWANA, R., & Kazama, I. (2022) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2022.01031 · Cited by 5
“Microglia are the brain-resident macrophages that produce pro-inflammatory cytokines within the central nervous system (3,4).”
BackgroundБокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Burbaeva, G. S. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040086 · Cited by 5
Лазаревна, А. Е., Gevorgyan, M. M., Zhanaeva, S. Y., Lipina, T. V., & Idova, G. V. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05225-0 · Cited by 5
Cognitive dysfunction in schizophrenia: association with peripheral blood inflammatory signatures
Luan, P., Wang, Q., Sun, Y., Jiang, C., Yin, J., & Wang, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07479-8 · Cited by 6
“Additionally, patients often exhibit broad psychosocial functional impairments that markedly affect occupational, social, and daily living activities, thereby imposing a substantial burden on both families and society [4, 5].”
Schizophrenia: from mechanism to therapy
Lu, Z., Sun, J., Zhao, G., Zhu, Y., Yuan, R., Zhou, J., Zhang, D., & Yue, W. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-2990-0 · Cited by 4
“Studies have indicated that inflammatory processes may be critical in the development of schizophrenia (Fond et al., 2020; Müller, 2018).”
Rietberg, T., Barbosa, S., Meysman, P., Aouizerate, B., Bellivier, F., Berna, F. S., Capdevielle, D., Chéreau, I., Courtet, P., Dondé, C., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106464 · Cited by 5
LINC01686 affects LPS‐induced cytokine expression via the miR‐18a‐5p/A20/STAT1 axis in THP‐1 cells
Baek, J., Shin, H., Suk, K., & Lee, W. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1234 · Cited by 3
“26 – 28 The inflammation process involves interactions between cells and inflammatory mediators, such as cytokines, chemokines, and cell surface proteins.”
BackgroundHu, C., Du, N., Li, J., Chen, L., Meng, X., Yao, L., Yu, T., Shi, L., & Zhang, X. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s506074 · Cited by 5
“Extensive research 23,24 has highlighted the pivotal role of inflammation in the pathophysiology of schizophrenia, where inflammatory factors are closely linked to alterations in brain structure and function.”
Bao, Y., Wang, W., Liu, Z., Wang, W., Zhao, X., Yu, S., & Lin, G. N. (2025) · Schizophrenia · doi:10.1038/s41537-025-00585-2 · Cited by 8
Dias, I. C. S., de Campos-Carli, S. M., Vieira, É. L. M., Mota, A. P. L., Azevedo, P. S., Anício, V. T. D. S., Guimarães, F. C., Mantovani, L. M., Cruz, B. F., Teixeira, A. L., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.020 · Cited by 4
Porozova, N. O., Danilova, E. Y., Senshinov, I. V., Tsakalof, A. K., & Nosyrev, A. E. (2022) · Molecules · doi:10.3390/molecules28010324 · Cited by 4
Matrisciano, F., & Pinna, G. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_22 · Cited by 6
Psychoneuroimmunology of depression and its relation to the gut-brain axis
Wahyuni, A. A. S., Vasmana, I. G., Evilia, W., & Marianto, M. (2023) · International journal of health & medical sciences · doi:10.21744/ijhms.v6n2.2146 · Cited by 4
“This term refers to the proinflammatory increase of the human basal gene expression profile (that is, the basal transcriptome) as a conserved transcriptional response to adversity (CTRA) (Miller & Goldsmith, 2019; Müller, 2018).”
BackgroundInfluentialAbdullahi, A., Wong, T. W. L., & Ng, S. S. M. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.10.004 · Cited by 6
Long non-coding RNAs in schizophrenia
Mousavinejad, S. N., Hosseini, S. A., Mohammadpour, M., Ferdosi, F., Dadgostar, E., Abdolghaderi, S., & Khatami, S. H. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120340 · Cited by 8
Prados-Ojeda, J. L., Luque, R., Gordillo-Urbano, R. M., Guler, I., Medina, C. L., Collantes‐Estévez, E., & Escudero‐Contreras, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163461 · Cited by 5
“In addition to their possible role in depression, inflammatory processes have been associated with the onset of psychotic symptoms [9,10].”
BackgroundInflammation and Immunity in Schizophrenia
Müller, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-71229-7_14 · Cited by 4
Self-citationWomen’s Midlife Health: Risk Factors and Disease Burden for Global Health
Dias, J. M., Subu, M. A., Abraham, M. S., & Al‐Yateem, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-45009-0_129 · Cited by 4
Kulu, M., Özsoy, F., & Demir, B. (2023) · Journal of Dependence · doi:10.51982/bagimli.1120280 · Cited by 4
Adrien, V., Bosc, N., Fumat, H., Tessier, C., Ferreri, F., Mouchabac, S., Tareste, D. C., & Nuss, P. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1089724 · Cited by 4
Vascular Schizophrenia-like Psychosis in Older Adults
Lauriola, M., D’Onofrio, G., Ciccone, F., la Torre, A., Angelillis, V. S., Germano, C., Cascavilla, L., & Greco, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144831 · Cited by 4
Development of neuropsychiatry over the last 30 years and the new era of Immuno-Psychiatry
Bechter, K. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100656 · Cited by 5
Juliani, P. Z., Rodrigues, T., Bressan, G. N., Camponogara, C., Oliveira, S. M., Brucker, N., & Fachinetto, R. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02793-z · Cited by 7
“…agent (Bastianetto et al. 2015; Zhang et al. 2021 ; Nguyen 2023 ), the alterations in dopaminergic/glutamatergic system as in schizophrenia (Müller 2018 ) or the use of antipsychotics (Peroza et al. 2016 ) are associated to alterations in cytokine levels, we investigated the effects of…”
Érosion prématurée des télomères et schizophrénies : synthèse et hypothèses
Corfdir, C., Pignon, B., Szöke, A., & Schürhoff, F. (2021) · L Encéphale · doi:10.1016/j.encep.2020.12.001 · Cited by 6
Joint-Tissue Integrative Analysis Identified Hundreds of Schizophrenia Risk Genes
Wu, Y., Yu, X., Xiao, X., Li, M., & Li, Y. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02572-x · Cited by 4
“As neuroinflammation has been studied for many years in the pathogenesis of schizophrenia [52], RNASEH2C might be related to schizophrenia through neuroinflammation.”
Backgroundde Bartolomeis, A., Vellucci, L., Barone, A., Manchia, M., Luca, V. D., Iasevoli, F., & Correll, C. U. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4089530 · Cited by 4
Biological Susceptibility of Patients with Schizophrenia to Metabolic Syndrome: A Review
Ma, J., Huang, Z., Chen, J., & Wang, G. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap39896 · Cited by 3
Cechnicki, A., Chrobak, A. A., Plencler, I., Stankiewicz, P., Kalisz, A., Błądziński, P., Kruk, D., Radoń, S., Szewczyk, B., Faron‐Górecka, A., et al. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00587-5 · Cited by 3
“…in addition to their involvement in inflammatory processes, these substances are involved in psychological stress response mediation [60], and (3) inflammatory markers play crucial roles in the stress response model [3] and in the mindfulness model of biological mechanisms according to Black [22].”
Chen, F., Hao, K., Shu, C., Xiong, Y., Xu, R., Huang, H., Peng, B., Liu, Z., Reynolds, G. P., Wang, G., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf153 · Cited by 6
“26 Impaired neuronal connectivity and synaptic plasticity are core components of schizophrenia pathogenesis.”
Изнак, А. Ф., Klyushnik, T. P., Zozulya, S. A., Изнак, Е. В., & Oleichik, I. V. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2022122111105 · Cited by 6
Kapıcı, Y., Tanrıverdi, Z., Tekın, A., Güc, B., Abuş, S., & Karamustafalıoğlu, O. (2023) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2023.08.013 · Cited by 3
Muneer, A., Saghir, H., Zahoor, A., Tariq, M., Din, H. U., & Abid, S. (2023) · Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University · doi:10.48036/apims.v19i3.839 · Cited by 3
Effect of Neurotropic and Immunotropic Drugs on Leukocyte Elastase Activity In Vitro
Zozulya, S. A., Sokolov, O. Y., & Кост, Н. В. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-024-06072-5 · Cited by 3
“According to modern concepts, the activation of inflammatory reactions is an essential pathogenetic link in mental diseases [1].”
Immunology of Schizophrenia: A Modern View on Inflammatory Hypotheses of the Disease
Klyushnik, T. P., & Zozulya, S. A. (2024) · Psikhiatriya · doi:10.30629/2618-6667-2024-22-4-14-25 · Cited by 3
Dai, S., Long, Y., Xiao, J., Wang, Y., Wang, X., Shao, P., Huang, M., Xu, Y., Liu, F., Tang, Y., et al. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104387 · Cited by 5
Moussiopoulou, J., & Falkai, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-81802-8_4 · Cited by 7
Zorina, I. I., & Shpakov, A. O. (2024) · Neurochemical Journal · doi:10.1134/s1819712424700247 · Cited by 3
Metadata
- Authors
- Müller, N.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Müller, Norbert
- ORCID
- Müller, Norbert
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-10
- Volume
- 44
- Issue
- 5
- Pages
- 973-982
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC6101562
- OpenAlex
- W2888647009
- Cited by
- 648
- References
- 130
- Citations by year
- 2026: 62 · 2025: 88 · 2024: 92 · 2023: 116 · 2022: 102 · 2021: 98 · 2020: 62 · 2019: 18 · 2018: 9
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Schizophrenia Bulletin (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- schizophrenia, neuroinflammation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.